Imeik Technology Development Co Ltd banner

Imeik Technology Development Co Ltd
SZSE:300896

Watchlist Manager
Imeik Technology Development Co Ltd Logo
Imeik Technology Development Co Ltd
SZSE:300896
Watchlist
Price: 116.42 CNY -1.62%
Market Cap: ¥35.2B

Imeik Technology Development Co Ltd's latest stock split occurred on Apr 29, 2024

The company executed a 1-for-1 stock split, meaning that for every share held, investors received 1 new share.

Before the split, Imeik Technology Development Co Ltd traded at 297.01 per share. Afterward, the share price was about 217.8.

The adjusted shares began trading on Apr 29, 2024. This was Imeik Technology Development Co Ltd's 2nd stock split, following the previous one in Mar 16, 2021.

Last Splits:
Apr 29, 2024
1-for-1
Mar 16, 2021
1-for-1
Pre-Split Price
209.827 297.01
Post-Split Price
217.8
Before
After
Last Splits:
Apr 29, 2024
1-for-1
Mar 16, 2021
1-for-1

Imeik Technology Development Co Ltd
Stock Splits History

Imeik Technology Development Co Ltd Stock Splits Timeline
Apr 29, 2024
Apr 29, 2024
Split 1-for-1
/1
Pre-Split Price
209.827 297.01
Post-Split Price
217.8
Before
After
Mar 16, 2021
Mar 16, 2021
Split 1-for-1
/1
Pre-Split Price
288.9733 750.8799
Post-Split Price
305.9471
Before
After

Global
Stock Splits Monitor

Date Company Split Pre-Split Price Post-Split Price
Apr 28, 2026
Kura Sushi Inc
TSE:2695
2-for-1
x2
3565 1782.5 JPY 1745 1745 JPY
Apr 28, 2026
Sanki Engineering Co Ltd
TSE:1961
3-for-1
x3
7020 2340 JPY 2413 2413 JPY
Apr 28, 2026
Hyterra Ltd
ASX:HYT
65-for-64
x1.015625
0.015 0.0148 AUD 0.015 0.015 AUD
Apr 28, 2026
Fit Corp
TSE:1436
3-for-1
x3
4065 1340 JPY 1269 1269 JPY
Apr 28, 2026
Visual Processing Japan Co Ltd
TSE:334A
2-for-1
x2
1844 922 JPY 965 965 JPY
Load More

Imeik Technology Development Co Ltd
Glance View

Market Cap
35.2B CNY
Industry
Biotechnology

Imeik Technology Development Co Ltd is a prominent player in the cosmetic medical industry, a sector that has experienced robust growth fueled by rising consumer demand for aesthetic enhancements. Situated in the heart of the beauty-conscious market of China, Imeik specializes in the development, manufacturing, and commercialization of medical aesthetic products, most notably hyaluronic acid fillers. These products, used extensively by dermatologists and beauty clinics, cater to individuals seeking non-invasive procedures to enhance their aesthetic appeal. By leveraging advanced biotechnological methodologies, Imeik has positioned itself as a trusted brand, gaining an edge through continual innovation and adherence to rigorous safety standards. The company's business model revolves around the strategic development and distribution of a diversified portfolio of aesthetic products. Imeik's revenue streams principally derive from the commercialization of its cutting-edge dermal fillers and other complementary medical solutions. By focusing on research and development, the company not only stays ahead of aesthetic trends but also ensures that its offerings maintain a high standard of efficacy and safety, essential in a sensitive market domain like medical aesthetics. Furthermore, Imeik’s collaborations with key stakeholders in the healthcare and cosmetic sectors amplify its reach, solidifying its market position and driving sustainable profitability. Through these endeavors, Imeik effectively captures a slice of the lucrative and rapidly growing beauty market, reinforcing its leadership within the industry.

Intrinsic Value
149.15 CNY
Undervaluation 22%
Intrinsic Value
Price ¥116.42
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett